Sinuwave Introduced to ENT Community at the American Rhinologic Society Conference

Clinicians attending the 59th Annual Meeting of the American Rhinologic Society Conference held on September 28th, 2013 in Vancouver were introduced to the Sinuwave™ Photodisinfection System. Sinuwave is the first Photodisinfection based therapy for the sinusitis market.  An abstract, entitled “Sinuwave Photodisinfection for the treatment of refractory chronic rhinosinusitis: a case series”, was submitted by researchers from the University of Montreal (Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM), Montreal, Canada) and presented at the Conference.

Sinuwave Photodisinfection System is Health Canada approved and was developed by Ondine Biomedical Inc. of Vancouver, the global leader in Photodisinfection, also known as antimicrobial Photodynamic Therapy (aPDT). Photodisinfection is a topical, non-antibiotic antimicrobial therapy that destroys a broad range of pathogens and their virulence factors, leading to a clinically observable anti-inflammatory effect.  Photodisinfection is a minimally invasive non-thermal therapy involving the light activation of a photosensitizer to eliminate topical infections in a highly targeted approach. Photodisinfection has been proven to be safe and effective in other applications such as for the dental and hospital acquired infection prevention markets. For more information about Sinuwave Photodisinfection, please visit www.sinuwave.com

Related Posts Plugin for WordPress, Blogger...

Leave a Reply

Staypressed theme by Themocracy